[Federal Register: July 3, 2007 (Volume 72, Number 127)]
[Notices]
[Page 36481]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr03jy07-84]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on March 19, 2007, Dade Behring
Inc., 100 GBC Drive, MS514, Post Office Box 6101, Attention: RA/QS,
Newark, Delaware 19714-6101, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the basic classes of controlled substances listed in
schedule I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)............... I
Benzoylecgonine (9180)..................... II
Morphine (9300)............................ II
------------------------------------------------------------------------
The company plans to produce the listed controlled substances in
bulk to be used in the manufacture of reagents and drug calibrator/
controls for DEA exempt products.
Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
should be addressed, in quintuplicate, to the Drug Enforcement
Administration, Office of Diversion Control, Federal Register
Representative (ODL), Washington, DC 20537, or any being sent via
express mail should be sent to Drug Enforcement Administration, Office
of Diversion Control, Federal Register Representative (ODL), 2401
Jefferson Davis Highway, Alexandria, Virginia 22301; and must be filed
no later than September 4, 2007.
Dated: June 26, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-12949 Filed 7-2-07; 8:45 am]
BILLING CODE 4410-09-P